Cannabis and psychosis
The tetrahydrocannabinol (THC) content of cannabis has roughly quintupled in the past 2 decades, from around 4% in the 2000s to more than 20% in most legal dried cannabis in Canada by 2023.[1][1] The lifetime occurrence of cannabis-induced psychosis symptoms is estimated to be 0.47% among people
Authors
- Sophie Li (ORCID: https://orcid.org/0000-0001-5301-4594)
- Nicholas Fabiano (ORCID: https://orcid.org/0000-0002-6873-5105)
- Daniel T. Myran (ORCID: https://orcid.org/0000-0002-8038-300X)
- Marco Solmi (ORCID: https://orcid.org/0000-0003-4877-7233)
Institutions
- University of Ottawa (CA)
- Ottawa Hospital (CA)
- International Council for the Exploration of the Sea (DK)
- Ottawa Public Health (CA)
- Bruyère (CA)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Canadian Medical Association Journal
- Published
- 2025-08-10
- DOI
- https://doi.org/10.1503/cmaj.250659
- Citations
- 2
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 2.79